Corporate ActionJul 6, 2026, 04:08 PM
Context Therapeutics Added to Russell 2000 & 3000 Indexes
AI Summary
Context Therapeutics Inc. announced its inclusion in the small-cap Russell 2000® Index and the broad-market Russell 3000® Index. This inclusion became effective at the close of U.S. equity markets on June 26, 2026. The Russell Indexes are widely used by investment managers for index funds and as benchmarks for active investment strategies, providing increased visibility for the company.
Key Highlights
- Context Therapeutics added to the Russell 2000® Index.
- Context Therapeutics added to the Russell 3000® Index.
- Inclusion effective at the close of U.S. equity markets on June 26, 2026.
- Russell 3000® Index measures performance of largest 3,000 U.S. companies.
- Russell 2000® Index is the leading benchmark for U.S. small-cap equities.
Price Impact
More from CNTX